Patent ID: 6028098
Filing Date: 2000-02-22
Classification: A61K,A61P,A61Q,Y10S

Abstract:
A pharmaceutical composition comprisinga topical preparation of a compound of general formula I, or a pharmaceutically acceptable salt thereof:Q--R--X (I)wherein Q is a substituted or unsubstituted pyrrolyl group, R is CR.sup.1.sub.2 --CR.sup.2.sub.2, (cis)CR.sup.1 .dbd.CR.sup.2, or (trans) --CR.sup.1 .dbd.CR.sup.2, X is COOR.sup.3 or NR.sup.1 R.sup.4, and R.sup.1 -R.sup.4 are each independently, H, or an alkyl or an aryl group, in an amount for therapeutic treatment of a skin condition which is responsive to UV irradiation and is selected from the group consisting of polymorphic light eruption, actinic purrigo, solar urticaria acne vulgaris, alopecia areata, dermatitis herpetiformis, eosinophilic pustular folliculitis, erythrokeratoderma, chronic lichenoid GVH disease, granuloma annulare, histiocvtosis X, ichthyosis linearis circumflexa, lichen planus, pityriasis lichenoides, pityriasis rosea, pityriasis rubra pilaris, subcorneal pustular dermatoses, transient acantholytic dermatoses, psoriasis and atopic eczema.